BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24135248)

  • 1. The landscape of histone acetylation involved in epithelial-mesenchymal transition in lung cancer.
    Zhang L; Liu Z; Ma W; Wang B
    J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S86-91. PubMed ID: 24135248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis.
    Meng F; Wu G
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):455-67. PubMed ID: 22733307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis.
    Wang Y; Shang Y
    Exp Cell Res; 2013 Jan; 319(2):160-9. PubMed ID: 22935683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
    Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
    Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone acetylation and methylation: combinatorial players for transcriptional regulation.
    An W
    Subcell Biochem; 2007; 41():351-69. PubMed ID: 17484136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone acetylation in gene regulation.
    Verdone L; Agricola E; Caserta M; Di Mauro E
    Brief Funct Genomic Proteomic; 2006 Sep; 5(3):209-21. PubMed ID: 16877467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of epithelial-mesenchymal transition by protein lysine acetylation.
    Kong F; Ma L; Wang X; You H; Zheng K; Tang R
    Cell Commun Signal; 2022 Apr; 20(1):57. PubMed ID: 35484625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib inhibits epithelial-mesenchymal transition through an epigenetic-based mechanism in human lung epithelial cells.
    Zhang J; Chen YL; Ji G; Fang W; Gao Z; Liu Y; Wang J; Ding X; Gao F
    PLoS One; 2013; 8(5):e64954. PubMed ID: 23741434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
    Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
    Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic control of ovarian function: the emerging role of histone modifications.
    LaVoie HA
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone acetylation and chromatin signature in stem cell identity and cancer.
    Shukla V; Vaissière T; Herceg Z
    Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross Talk Mechanism among EMT, ROS, and Histone Acetylation in Phorbol Ester-Treated Human Breast Cancer MCF-7 Cells.
    Kamiya T; Goto A; Kurokawa E; Hara H; Adachi T
    Oxid Med Cell Longev; 2016; 2016():1284372. PubMed ID: 27127545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global histone modifications predict prognosis of resected non small-cell lung cancer.
    Barlési F; Giaccone G; Gallegos-Ruiz MI; Loundou A; Span SW; Lefesvre P; Kruyt FA; Rodriguez JA
    J Clin Oncol; 2007 Oct; 25(28):4358-64. PubMed ID: 17906200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lung cancer and its epigenetics association with chronic obstructive pulmonary disease].
    Xu PW; Jin YT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):70-3. PubMed ID: 23450484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
    Katsuno Y; Lamouille S; Derynck R
    Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Epigenetic Regulation of Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancer Cells by Quantitative Chromatin Immunoprecipitation of Histone Deacetylase 3 (HDAC3).
    Wang JQ; Wu MZ; Wu KJ
    Methods Mol Biol; 2016; 1436():23-9. PubMed ID: 27246206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant histone acetylation and methylation levels in woman with endometriosis.
    Xiaomeng X; Ming Z; Jiezhi M; Xiaoling F
    Arch Gynecol Obstet; 2013 Mar; 287(3):487-94. PubMed ID: 23080547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
    Cuomo A; Moretti S; Minucci S; Bonaldi T
    Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition.
    Wu CY; Tsai YP; Wu MZ; Teng SC; Wu KJ
    Trends Genet; 2012 Sep; 28(9):454-63. PubMed ID: 22717049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.